Home›Research›Compare›Epithalon vs Foxo4-DRI
Peptide ComparisonEpithalon vs Foxo4-DRI
Both are Longevity & Cellular peptides.
Epithalon
Epitalon
Half-life: 30–60 minutes
173 providers listed
Foxo4-DRI
Foxo4-D-Retro-Inverso
Half-life: Unknown
13 providers listed
Epithalon carries stronger published evidence (RCT, 2 key studies) than Foxo4-DRI (Review, 3); both are research compounds.
Epithalon
Evidence
Half-life
30–60 minutes
Foxo4-DRI
Evidence
Half-life
Unknown
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | Epithalon |
| Lower typical price per mg | Epithalon |
| More provider options (173 vs 13) | Epithalon |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
Epithalon
Foxo4-DRI
Epithalon
Foxo4-DRI
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging
Targeting the FOXO4-p53 axis by retro-inverso peptide senolytic agents: a pharmacological strategy to mitigat…
Rational design of a peptide inducing selective apoptosis of p53-high senescent cells by targeting the FOXO4-…
About Epithalon
Epithalon is believed to activate telomerase, the enzyme responsible for maintaining telomere length, with several in vitro and animal studies reporting telomere elongation. It also appears to regulate the expression of p53 and other cell-cycle control genes, modulate the hypothalamic-pituitary axis via pineal gland activity, and upregulate antioxidant defences including superoxide dismutase and catalase.
About Foxo4-DRI
D-retro-inverso peptide that disrupts Foxo4/p53 interaction in senescent cells; restores p53-mediated apoptosis selectively in senescent cells; clears cellular "zombie cells"
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
Epithalon
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Foxo4-DRI
Under clinical review
Being verified by our medical team before we display contraindications for this peptide.
Epithalon
GHK-Cu
Research suggests Epithalon and GHK-Cu may produce complementary longevity-associated effects when combined. Epithalon is studied for telomere maintenance and pineal function, while GHK-Cu is studied for antioxidant gene expression and tissue remodeling — different mechanisms in aging research.
Epithalon
Foxo4-DRI
Where to source these peptides
Epithalon
173 listed
Browse directory →
Providers offeringFoxo4-DRI
13 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Longevity & Cellular Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated July 27, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). Epithalon vs Foxo4-DRI — Per-mg Price Comparison. Retrieved July 29, 2026, from https://peptidebase.io/peptides/compare/epithalon/foxo4-dri